Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
NeuroVoices: Fabian Somers, PhD, on the First Approved Drug for Thymidine Kinase 2 Deficiency
2
Phase 2 VIBRANCE-2 Findings Further Support Orexin-Targeting Treatment Alixorexton in Narcolepsy
3
Next Phase of Genetic Counseling in Clinical Trials: Derek Ansel, MS, CGC
4
Reflecting on the 2025 Annual Women in Neurology (WNG) Conference: Amy Hessler, DO
5
